 |
市場調查報告書
商品編碼
1166496
麩胺基硫的全球市場:市場規模 - 各類型，各產品，各用途，各地區展望，競爭策略，各市場區隔預測(～2032年)Glutathione Market Size- By Type, By Product, By Application- Regional Outlook, Competitive Strategies and Segment Forecasts to 2032 |
||||||
全球麩胺基硫的市場規模，預計至2032年達到10億3,000萬美元，以8.8％的年複合成長率成長。
麩胺基硫，預計在全球醫藥品及食品部門的市場佔有率擴大。由於COVID-19影響，為緩和症狀囤積成藥的人變多。免疫力強化的商品需求也擴大，健康輔助食品的需求也高漲。大流行時，由於一般醫藥品需求增加，麩胺基硫的市場預計增加。
本報告提供全球麩胺基硫市場相關調查，市場動態，市場變數與展望，各類型、產品、用途、地區的市場分析，企業簡介等相關資訊。
目錄
第1章 簡介
- 調查範圍
- 市場區隔分析
第2章 調查手法
- 調查資料來源
- 市場規模的估計
- 資料的三角測量
第3章 摘要整理
第4章 市場動態
- 促進因素，阻礙因素，機會，課題的分析
- 促進因素
- 阻礙因素
- 機會
- 課題
- 全球麩胺基硫市場上COVID-19的影響
第5章 市場變數與展望
- SWOT分析
- 優勢
- 弱點
- 機會
- 威脅
- PESTEL分析
- 政治形勢
- 經濟形勢
- 社會形勢
- 技術形勢
- 環境形勢
- 法律上的形勢
- 波特的五力分析
- 供給企業談判力
- 買方議價能力
- 替代品的威脅
- 新加入廠商的威脅
- 競爭企業間的敵對關係
- 熱圖分析
第6章 全球麩胺基硫市場:各類型，2019年～2032年(100萬美元)
- L-麩胺基硫
- 乙醯麩胺基硫
第7章 全球麩胺基硫市場:各產品，2019年～2032年(100萬美元)
- 氧化型麩胺基硫
- 還原型麩胺基硫
第8章 全球麩胺基硫市場:各用途，2019年～2032年(100萬美元)
- 食品、飲料
- 免疫沉澱(IP)
- 個人保養品、化妝品
- 醫藥品
- 蛋白質純化
- 研究
- 其他
第9章 全球麩胺基硫市場:各地區，2019年～2032年(100萬美元)
- 北美
- 美國
- 加拿大
- 墨西哥
- 歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 其他的歐洲
- 亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 其他的亞太地區
- 南美
- 巴西
- 阿根廷
- 其他的南美
- 中東、非洲
- 沙烏地阿拉伯王國
- 阿拉伯聯合大公國
- 其他的中東、非洲
第10章 企業簡介
- Bio-Rad Laboratories Inc.
- 企業概要
- 財務預測
- 產品概要
- 最近的開發
- Cytiva
- Jarrow Formulas Inc.
- Kaiping Genuine Biochemical Pharmaceutical Co. Ltd.
- Kohjin Life Sciences Co. Ltd.
- Kyowa Hakko Bio Co. Ltd.
- Merck KGaA
- Mitsubishi Corporation Life Sciences Ltd.
- Nissor Pharmaceuticals Ltd.
- Shandong Jincheng Biological Pharmaceutical Co. Ltd.
- Shenzhen GSH Bio-Technology Co. Ltd.
- Takara Bio Inc.
- Thermo Fisher Scientific Inc.
Global Glutathione Market Overview:
According to SPER Market Research, the Global Glutathione Market is estimated to reach USD 1.03 billion by 2032 with a CAGR of 8.8%.
A tripeptide substance called glutathione is created from the amino acid glycine, cysteine, and glutamic acid. Important cellular components of the human body are susceptible to damage from reactive oxygen species, including free radicals, peroxides, lipid peroxides, and heavy metals. Glutathione aids in avoiding this damage. An essential antioxidant in the human body, glutathione helps fight free radicals, detoxify substances produced naturally by the body, as well as pharmaceuticals and environmental contaminants. Additionally, glutathione is used to treat impaired immune systems, infertility, and cancer's damaging side effects from radiation and chemotherapy. These advantages of the product ought to increase glutathione's market share in the global pharmaceutical and food sectors.
Impact of COVID-19 on the Global Glutathione Market
The COVID-19 epidemic has altered customers' purchasing behaviour. Panic purchases of food and sanitary supplies have resulted from measures like the countrywide lockdown. A growing number of patients are preferring self-medication over doctor visits in the wake of the COVID-19 issue. As a result, many people have stocked up on over-the-counter medications for symptom alleviation. The demand for goods that aid in strengthening immunity has also grown as a result of greater consumer knowledge of and interest in the significance of preventative health. The need for health supplements has increased as a result. During the pandemic, the market for glutathione is anticipated to rise because to the general increase in demand for medications.
Scope of the Report:
Report Metric Details
- Market size available for years: 2019-2032
- Base year considered: 2021
- Forecast period: 2022-2032
- Segments covered: By Type, By Product, By Application
- Regions covered: North America, Europe, Asia Pacific, Latin America, Middle East and Africa
- Companies Covered: Bio-Rad Laboratories Inc., Cytiva, Jarrow Formulas Inc., Kaiping Genuine Biochemical Pharmaceutical Co. Ltd., Kohjin Life Sciences Co. Ltd., Kyowa Hakko Bio Co. Ltd., Merck KGaA, Mitsubishi Corporation Life Sciences Ltd., Nissor Pharmaceuticals Ltd., Shandong Jincheng Biological Pharmaceutical Co. Ltd., Shenzhen GSH Bio-Technology Co. Ltd., Takara Bio Inc., Thermo Fisher Scientific Inc.
Global Glutathione Market Segmentation:
- By Type: Based on the Type, Global Glutathione Market is segmented as; L-Glutathione, Acetyl-Glutathione.
- By Product: Based on the Product, Global Glutathione Market is segmented as; Oxidized Glutathione, Reduced Glutathione.
- By Application: Based on the Application, Global Glutathione Market is segmented as; Food & Beverages, Immunoprecipitation, Personal Care & Cosmetics, Pharmaceuticals, Protein Purification, Research, Others.
- By Region: Over the projected period, Asia Pacific is expected to develop at the quickest CAGR of any major region, accounting for the greatest revenue share of all other regions. This share is attributable to the expanding government support for domestic manufacturing, which is predicted to increase output levels and lessen reliance on imports in the Asia Pacific area, providing profitable prospects for international manufacturers. Over the projected period, the market is also anticipated to be driven by the expanding pharmaceutical R&D industry. In terms of volume, North America is the largest market, and it is anticipated that it would expand at a significant CAGR over the forecast period. The development of vaccines to treat illnesses like the present Coronavirus pandemic and the increased need for biochemical research applications are two key reasons driving the regional industry. Demand for the product is anticipated to increase in North America due to the growing use of purified proteins and antibodies in medicinal applications.
Table of Contents
1. Introduction
- 1.1. Scope of the report
- 1.2. Market segment analysis
2. Research Methodology
- 2.1 Research data source
- 2.1.1 Secondary data
- 2.1.2 Primary data
- 2.1.3 SPER's internal database
- 2.1.4 Premium insight from KOL's
- 2.2 Market size estimation
- 2.2.1 Top-down and Bottom-up approach
- 2.3 Data triangulation
3. Executive Summary
4. Market Dynamics
- 4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1 Drivers
- 4.1.2 Restraints
- 4.1.3 Opportunities
- 4.1.4 Challenges
- 4.2. COVID-19 Impacts of the Global Glutathione Market
5. Market variables and outlook
- 5.1. SWOT analysis
- 5.1.1 Strengths
- 5.1.2 Weaknesses
- 5.1.3 Opportunities
- 5.1.4 Threats
- 5.2. PESTEL analysis
- 5.2.1 Political landscape
- 5.2.2 Economic landscape
- 5.2.3 Social landscape
- 5.2.4 Technological landscape
- 5.2.5 Environmental landscape
- 5.2.6 Legal landscape
- 5.3. PORTER'S five forces analysis
- 5.3.1 Bargaining power of suppliers
- 5.3.2 Bargaining power of Buyers
- 5.3.3 Threat of Substitute
- 5.3.4 Threat of new entrant
- 5.3.5 Competitive rivalry
- 5.4. Heat map analysis
6. Global Glutathione Market, By Type, 2019-2032 (USD Million)
- 6.1. L-Glutathione
- 6.2. Acetyl-Glutathione
7. Global Glutathione Market, By Product, 2019-2032 (USD Million)
- 7.1. Oxidized Glutathione
- 7.2. Reduced Glutathione
8. Global Glutathione Market, By Application, 2019-2032 (USD Million)
- 8.1. Food & Beverages
- 8.2. Immunoprecipitation (IP)
- 8.3. Personal Care & Cosmetics
- 8.4. Pharmaceuticals
- 8.5. Protein Purification
- 8.6. Research
- 8.7. Others
9. Global Glutathione Market, By Region, 2019-2032 (USD Million)
- 9.1 North America
- 9.1.1 United States
- 9.1.2 Canada
- 9.1.3 Mexico
- 9.2 Europe
- 9.2.1 Germany
- 9.2.2 United Kingdom
- 9.2.3 France
- 9.2.4 Italy
- 9.2.5 Spain
- 9.2.6 Rest of Europe
- 9.3 Asia-Pacific
- 9.3.1 China
- 9.3.2 Japan
- 9.3.3 India
- 9.3.4 Australia
- 9.3.5 South Korea
- 9.3.6 Rest of Asia-Pacific
- 9.4 South America
- 9.4.1 Brazil
- 9.4.2 Argentina
- 9.4.3 Rest of South America
- 9.5 Middle East & Africa
- 9.5.1 Kingdom of Saudi Arabia
- 9.5.2 United Arab Emirates
- 9.5.3 Rest of Middle East & Africa
10. Company Profiles
- 10.1 Bio-Rad Laboratories Inc.
- 10.1.1 Company details
- 10.1.2 Financial outlook
- 10.1.3 Product summary
- 10.1.4 Recent developments
- 10.2 Cytiva
- 10.2.1 Company details
- 10.2.2 Financial outlook
- 10.2.3 Product summary
- 10.2.4 Recent developments
- 10.3 Jarrow Formulas Inc.
- 10.3.1 Company details
- 10.3.2 Financial outlook
- 10.3.3 Product summary
- 10.3.4 Recent developments
- 10.4 Kaiping Genuine Biochemical Pharmaceutical Co. Ltd.
- 10.4.1 Company details
- 10.4.2 Financial outlook
- 10.4.3 Product summary
- 10.4.4 Recent developments
- 10.5 Kohjin Life Sciences Co. Ltd.
- 10.5.1 Company details
- 10.5.2 Financial outlook
- 10.5.3 Product summary
- 10.5.4 Recent developments
- 10.6 Kyowa Hakko Bio Co. Ltd.
- 10.6.1 Company details
- 10.6.2 Financial outlook
- 10.6.3 Product summary
- 10.6.4 Recent developments
- 10.7 Merck KGaA
- 10.7.1 Company details
- 10.7.2 Financial outlook
- 10.7.3 Product summary
- 10.7.4 Recent developments
- 10.8 Mitsubishi Corporation Life Sciences Ltd.
- 10.8.1 Company details
- 10.8.2 Financial outlook
- 10.8.3 Product summary
- 10.8.4 Recent developments
- 10.9 Nissor Pharmaceuticals Ltd.
- 10.9.1 Company details
- 10.9.2 Financial outlook
- 10.9.3 Product summary
- 10.9.4 Recent developments
- 10.10 Shandong Jincheng Biological Pharmaceutical Co. Ltd.
- 10.10.1 Company details
- 10.10.2 Financial outlook
- 10.10.3 Product summary
- 10.10.4 Recent developments
- 10.11 Shenzhen GSH Bio-Technology Co. Ltd.
- 10.11.1 Company details
- 10.11.2 Financial outlook
- 10.11.3 Product summary
- 10.11.4 Recent developments
- 10.12 Takara Bio Inc.
- 10.12.1 Company details
- 10.12.2 Financial outlook
- 10.12.3 Product summary
- 10.12.4 Recent developments
- 10.13 Thermo Fisher Scientific Inc.
- 10.13.1 Company details
- 10.13.2 Financial outlook
- 10.13.3 Product summary
- 10.13.4 Recent developments
